Syndax Pharmaceuticals, Inc. (SNDX)
20.11
+0.54
(+2.76%)
USD |
NASDAQ |
Aug 25, 10:34
Syndax Pharmaceuticals 1 Year Total Returns (Daily) : 20.50% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 20.50% |
| August 21, 2026 | 24.05% |
| August 20, 2026 | 25.48% |
| August 19, 2026 | 34.91% |
| August 18, 2026 | 25.49% |
| August 17, 2026 | 25.54% |
| August 14, 2026 | 34.69% |
| August 13, 2026 | 41.86% |
| August 12, 2026 | 52.66% |
| August 11, 2026 | 62.19% |
| August 10, 2026 | 63.22% |
| August 07, 2026 | 60.38% |
| August 06, 2026 | 53.30% |
| August 05, 2026 | 58.47% |
| August 04, 2026 | 83.82% |
| August 03, 2026 | 92.79% |
| July 31, 2026 | 92.04% |
| July 30, 2026 | 95.00% |
| July 29, 2026 | 85.70% |
| July 28, 2026 | 105.1% |
| July 27, 2026 | 113.1% |
| July 24, 2026 | 108.3% |
| July 23, 2026 | 107.5% |
| July 22, 2026 | 113.9% |
| July 21, 2026 | 132.7% |
| Date | Value |
|---|---|
| July 20, 2026 | 135.6% |
| July 17, 2026 | 135.8% |
| July 16, 2026 | 145.5% |
| July 15, 2026 | 155.4% |
| July 14, 2026 | 145.0% |
| July 13, 2026 | 138.7% |
| July 10, 2026 | 140.4% |
| July 09, 2026 | 168.8% |
| July 08, 2026 | 180.7% |
| July 07, 2026 | 166.2% |
| July 06, 2026 | 145.3% |
| July 02, 2026 | 142.4% |
| July 01, 2026 | 136.8% |
| June 30, 2026 | 133.4% |
| June 29, 2026 | 140.9% |
| June 26, 2026 | 129.1% |
| June 25, 2026 | 122.6% |
| June 24, 2026 | 116.7% |
| June 23, 2026 | 113.4% |
| June 22, 2026 | 103.8% |
| June 18, 2026 | 96.08% |
| June 17, 2026 | 97.51% |
| June 16, 2026 | 85.69% |
| June 15, 2026 | 80.29% |
| June 12, 2026 | 71.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Viking Therapeutics, Inc. | 27.81% |
| Kura Oncology, Inc. | 62.09% |
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |